Agios Pharm Net Asset Quality Index
Agios Pharm net asset quality index. Agios Pharm (AGIO) has a Net Asset Quality Index of 92.6% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.11 Billion minus total liabilities of $82.40 Million yields net assets of $1.03 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check AGIO cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Agios Pharm (2011–2025)
Net asset quality index of Agios Pharm from 2011 to 2025. This chart shows how Agios Pharm's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the index stands at 92.6%, representing net assets of $1.03 Billion against total assets of $1.11 Billion USD. See AGIO book value for net asset value and shareholders' equity analysis.
Agios Pharm Net Asset Quality Index by Year (2011–2025)
Agios Pharm net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for Agios Pharm from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see AGIO market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | $1.19 Billion | $1.30 Billion | $104.11 Million | ▼ -0.7 pp |
| 2024 | 92.7% | $1.54 Billion | $1.66 Billion | $122.24 Million | ▲ +6.1 pp |
| 2023 | 86.5% | $811.02 Million | $937.12 Million | $126.10 Million | ▼ -2.3 pp |
| 2022 | 88.9% | $1.10 Billion | $1.24 Billion | $137.90 Million | ▼ -1.0 pp |
| 2021 | 89.9% | $1.29 Billion | $1.44 Billion | $145.76 Million | ▲ +43.0 pp |
| 2020 | 46.8% | $399.50 Million | $852.95 Million | $453.45 Million | ▼ -25.1 pp |
| 2019 | 71.9% | $640.53 Million | $890.74 Million | $250.21 Million | ▼ -8.2 pp |
| 2018 | 80.1% | $687.54 Million | $858.46 Million | $170.92 Million | ▲ +19.0 pp |
| 2017 | 61.1% | $375.50 Million | $614.40 Million | $238.89 Million | ▲ +3.2 pp |
| 2016 | 57.9% | $358.59 Million | $619.09 Million | $260.50 Million | ▼ -24.2 pp |
| 2015 | 82.2% | $345.12 Million | $420.06 Million | $74.95 Million | ▼ -4.1 pp |
| 2014 | 86.3% | $424.37 Million | $491.90 Million | $67.54 Million | ▲ +20.9 pp |
| 2013 | 65.3% | $131.48 Million | $201.21 Million | $69.72 Million | ▲ +33.3 pp |
| 2012 | 32.0% | $43.90 Million | $137.01 Million | $93.11 Million | ▼ -0.4 pp |
| 2011 | 32.5% | $63.14 Million | $194.47 Million | $131.33 Million | — |